|
|
楼主 |
发表于 2015-1-31 09:55:59
|
显示全部楼层
目录:9 w3 \5 u M4 X, ? ~9 Z% N
Virus Infection and Human Cancer: An Overview . . . . . . . . . . . . . . . 11 w8 E9 v7 |) z) N& J. D' {4 e
John T. Schiller and Douglas R. Lowy* Y8 r- L" c9 @5 A9 A0 t
Epidemiology of Virus Infection and Human Cancer . . . . . . . . . . . . . 11! m8 u- d N1 _
Chien-Jen Chen, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee,
' v% \3 ^( O8 N0 u1 ~Hui-Chi Chen, Yin-Chu Chien and San-Lin You4 x1 g" {9 x# C
Virus Infection, Inflammation and Prevention of Cancer . . . . . . . . . . 33
5 e$ @) S: k; g3 p$ w0 oNorman Woller and Florian Kühnel
8 J4 {9 ~. p8 ~The Oncogenic Role of Hepatitis B Virus . . . . . . . . . . . . . . . . . . . . . . 59
# L7 r R# ^* A5 yLise Rivière, Aurélie Ducroux and Marie Annick Buendia% y' c, c, @" H6 w: G! K# P
Prevention of Hepatitis B Virus Infection and Liver Cancer . . . . . . . . 75& B; ?& h& ?! Y* J
Mei-Hwei Chang
& H5 s/ A$ ^9 h! l" KThe Oncogenic Role of Hepatitis C Virus. . . . . . . . . . . . . . . . . . . . . . 97# S& |3 X1 `' g4 E" S3 \. ?
Kazuhiko Koike
" S2 q/ k N, y+ f4 H& ]Prevention of Hepatitis C Virus Infection and Liver Cancer . . . . . . . . 113, [: F8 p1 G# X
E. J. Lim and J. Torresi
, z9 @, c: a( X0 s2 \1 h3 K, YThe Role of Human Papillomaviruses in Oncogenesis . . . . . . . . . . . . . 135
0 O2 H2 f' ], r/ S( b+ A; N2 I+ }Kristen K. Mighty and Laimonis A. Laimins, W5 T% I3 {0 x2 x) ?
Control of HPV Infection and Related Cancer( w; y9 [ F9 _' B* f2 s. j
Through Vaccination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149! s; A. o9 o) E6 \, ~
Nam Phuong Tran, Chien-Fu Hung, Richard Roden and T.-C. Wu: Y$ O0 z9 n; {2 }9 k3 V, r
Prevention and Treatment for Epstein–Barr Virus Infection; x+ \# c7 J- M( s3 H4 t6 t8 O, Y
and Related Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
# d' _3 l& b3 f" dFrançoise Smets and Etienne M. Sokal
, G# B+ S0 Y1 F& OHTLV-1 and Leukemogenesis: Virus–Cell Interactions, x/ W+ I2 o, I1 u) x3 }" p
in the Development of Adult T-Cell Leukemia . . . . . . . . . . . . . . . . . . 191
* ]( Z$ `4 b" v! u2 YLinda Zane and Kuan-Teh Jeang4 t& y* A2 H: S
Prevention of Human T-Cell Lymphotropic Virus Type 1
# |; c$ i5 S0 s, z& x) [: ^4 ?Infection and Adult T-Cell Leukemia/Lymphoma. . . . . . . . . . . . . . . . 211
& W) Y5 L) ~; J* YMakoto Yoshimitsu, Yohann White and Naomichi Arima9 C; ?2 a! h, D7 o- P! |6 _9 f
Molecular Biology of Human Herpesvirus 8: Novel Functions+ G8 f$ A! V) \% O
and Virus–Host Interactions Implicated in Viral Pathogenesis+ F& e6 \( U) ?8 ~& d
and Replication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2277 ?, |% l* Q) R& c2 f! } j
Emily Cousins and John Nicholas
2 I5 p2 x/ S7 e4 N% X' j$ fAnti-Viral Treatment and Cancer Control . . . . . . . . . . . . . . . . . . . . . 269
2 r: R; H% w) x2 M! SWei-Liang Shih, Chi-Tai Fang and Pei-Jer Chen |
|